Detect. Prevent. Thrive.

Silent heart risks don’t wait.

Neither do we.

MbeleMed is the first platform built to screen entire populations for silent arrhythmias—and turn early detection into prevention, care, and measurable ROI.

THE PROBLEM

Every 15 seconds, an undetected arrhythmia sends someone to the ER. Every day, nearly 100 families lose someone to a stroke or heart attack that silent AFib could have prevented.

The system fails because it isn’t looking.

• Fewer than 1% of seniors are ever monitored.

• Just 0.3% of Black seniors and 0.2% of rural seniors are screened.

• Clinics lack the tools, time, and billing pathways to act early.

The result: preventable deaths, avoidable costs, and families blindsided by conditions that could have been managed.

What the System Misses

OUR SOLUTION

Early Detection

That Works at Scale

MbeleMed fixes the broken first mile of cardiac screening.

OUR PLATFORM:

Flags high-risk patients using AI risk stratification

1.

2.

Delivers devices to home, clinic, or mobile sites

3.

Detects silent arrhythmias (AFib, SVT, pauses, tachycardia)

4.

Routes results through a smart triage engine—routine, urgent, or critical

5.

Issues CMS-compliant reports that enable billing and follow-up

No clinic burden.

No missed patients.

Just risk caught early

and acted on immediately.

Everyone Wins When We Detect Early

  • PATIENTS

    Early detection and intervention, access to drugs, coordinated care, clinical trials, and prevention of strokes and heart attacks.

  • CLINICS & CLINICIANS

    Empowered to screen and manage their own patients, improving quality measures and earning bonus payments.

  • CMS

    Reduces lifetime costs by targeting early intervention at high-risk cohorts

  • PAYORS / HEALTH PLANS

    Lowers risk and cost, boosts STAR scores, and secures ROI-positive adoption of GLP-1 therapies.

  • PHARMA

    Gains near real-time cardiac data, accelerates GLP-1 adoption, and accesses harder-to-reach cohorts.

  • COMMUNITIES

    Healthier populations, fewer ER visits, and improved equity in care.

  • EMPLOYERS

    Reduced absenteeism and disability claims, lower premiums over time.

  • MBELE MED

    Scales sustainably on a per-detection model, with growth tied directly to better patient outcomes.

Built for Trust and Scale

  • AI Roadmap From detection to prediction, getting smarter every year

  • Regulatory Strength HIPAA, SOC 2, HITRUST compliance

  • Billing Integrity Audit-ready workflows; clean claims; CMS alignment

About Us

Founded by Philip Butler, a Wharton-trained operator whose father’s undiagnosed AFib shaped this mission.

Backed by system-builders and clinical leaders who know the stakes and have scaled solutions before.

Get in Touch

We’re building the first prevention-first cardiac screening platform that works for everyone.

If you’re a clinician, payor, policymaker, or investor—we want to talk.

Let’s prevent what the system misses.